Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL15333412 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL199336 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL2807134 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL28580914 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL19665772 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL900388 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL29216461 | 1.00 | MEN1 (0.67) | MEN1KMT2ATSHRCA5ACA5B | |
| SCHEMBL8897 | 0.94 | MEN1 (0.75) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL2590832 | 0.94 | MEN1 (0.75) | MEN1KMT2ATSHRCA5ACA5B | |
| Water SCHEMBL10566608 | 0.94 | MEN1 (0.75) | MEN1KMT2ATSHRCA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079186-A | Gallium silicon molecular sieve and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-118145964-B | Iron-doped gallium oxide-based strong ferromagnetic ceramic film material and preparation method thereof | 成都昆仑玉丘科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122037227-A | Gallium metal organic framework material and preparation method and application thereof | 南方医科大学珠江医院 | 2026-05-15 | — | — | CN | claimed |
| US-12605487-B2 | Metal substrate with antibacterial and osteointegrative properties for implantology applications | MEDACTA INTERNATIONAL SA (CH) | 2026-04-21 | — | — | US | claimed |
| CN-121570590-A | Composite material for treating periodontitis based on photodynamic force and preparation method and application thereof | 南昌大学第二附属医院 | 2026-02-27 | — | — | CN | claimed |
| US-12550378-B2 | IGZO thin-film transistor and method for manufacturing same | SOUTHEAST UNIVERSITY (CN) | 2026-02-10 | — | — | US | claimed |
| EP-4630187-A1 | PRODUCTION OF SILVER NANOPARTICLES BY GREEN SYNTHESIS USING HAZELNUT HUSK EXTRACT | Bahçesehir Üniversitesi (TR) | 2025-10-15 | — | — | EP | claimed |
| US-20250249440-A1 | PROCESS AND CATALYST FOR CATALYTIC CRACKING OF NAPHTHA TO LIGHT OLEFINS AND AROMATICS | HINDUSTAN PETROLEUM CORPORATION LIMITED (IN) | 2025-08-07 | — | — | US | claimed |
| US-20250215314-A1 | PRECURSOR MATERIAL FOR SYNTHESIS OF GROUP III-V QUANTUM DOTS AND PREPARATION METHOD THEREFOR | Research & Business Foundation Sungkyunkwan University (KR) | 2025-07-03 | — | — | US | claimed |
| CN-119419299-B | Platinum-palladium-based multi-element alloy sub-nanobelt catalyst and preparation method and application thereof | 北京科技大学 | 2025-06-24 | — | — | CN | claimed |
| JP-2011506455-A | — | — | 2011-03-03 | — | — | JP | claimed |
| US-20100272717-A1 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER | NOVARTIS AG (CH) | 2010-10-28 | — | — | US | claimed |
| US-20100251936-A1 | METHOD OF FABRICATING LIQUID FOR OXIDE THIN FILM | INDUSTRY-ACADEMIC COOPERATION FOUNDATION , (KR) | 2010-10-07 | — | — | US | claimed |
| EP-2231147-A2 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER | Novartis AG (CH) | 2010-09-29 | — | — | EP | claimed |
| WO-2010025720-A2 | IMPLANT AND METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | VEREIN ZUR FÖRDERUNG VON INNOVATIONEN DURCH FORSCHUNG, ENTWICKLUNG UND TECHNOLOGIETRANSFER E. V. (VEREIN INNOVENT E.V.) (DE) | 2010-03-11 | — | — | WO | claimed |
| WO-2009076170-A2 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER | NOVARTIS AG (CH) | 2009-06-18 | — | — | WO | claimed |
| US-7547953-B2 | Porous gallium oxide films and methods for making and patterning the same | GENERAL ELECTRIC COMPANY (US) | 2009-06-16 | — | — | US | claimed |
| WO-2009054574-A1 | METHOD OF FABRICATING LIQUID FOR OXIDE THIN FILM | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2009-04-30 | — | — | WO | claimed |
| US-20080180209-A1 | Porous gallium oxide films and methods for making and patterning the same | GENERAL ELECTRIC COMPANY | 2008-07-31 | — | — | US | claimed |
| US-4225511-A | Direct oximation of ketones using gallia catalysts | ALLIED CHEMICAL CORPORATION (US) | 1980-09-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12550378-B2 | IGZO thin-film transistor and method for manufacturing same | PTPRO, PTPRZ1, IKZF3 | MEN1 4562/4885KMT2A 2869/4885TSHR 885/4885 |
| US-20100272717-A1 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER | ANXA5, BAX, ANXA6 | MEN1 2299/4885KMT2A 2057/4885TSHR 4483/4885 |
| US-12605487-B2 | Metal substrate with antibacterial and osteointegrative properties for implantology applications | BMP2, SOST, ACP3 | MEN1 4165/4885KMT2A 3731/4885TSHR 3031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.